Arrowhead Research | ARWR - 営業経費

株価
69.38
毎日の変更
-1.15 -1.63%
毎月
20.35%
毎年
399.50%
Q2 予測
72.33




営業経費 変化する 日付
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Anika Therapeutics USD 133.9M 103.93M 2026-03
Arrowhead Research USD 223.22M 10.86M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Incyte USD 5.62B 4.5B 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Merck USD 10.16B 558M 2025-12
Moderna USD 1.54B 259M 2025-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novartis USD 9.8B 61M 2025-12
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
TG Therapeutics USD 142.08M 9.74M 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Xencor USD 81.86M 13.35M 2025-12